HEADER LYASE 02-MAR-23 8IL7 TITLE STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH LACTATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AH-RELATED PROTEIN,ADENYLATE CYCLASE HOMOLOG; COMPND 5 EC: 4.6.1.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS SAC, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.J.LI,Z.L.LI,P.GAO REVDAT 1 26-JUL-23 8IL7 0 JRNL AUTH Q.J.LI,Z.L.LI,P.GAO JRNL TITL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH JRNL TITL 2 LACTATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 40207 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.164 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 2003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.6400 - 4.7000 0.99 2760 150 0.1948 0.2211 REMARK 3 2 4.7000 - 3.7300 1.00 2739 161 0.1424 0.1483 REMARK 3 3 3.7300 - 3.2600 1.00 2725 151 0.1545 0.1738 REMARK 3 4 3.2600 - 2.9600 1.00 2753 129 0.1678 0.1665 REMARK 3 5 2.9600 - 2.7500 1.00 2701 156 0.1746 0.2043 REMARK 3 6 2.7500 - 2.5900 1.00 2770 110 0.1697 0.1945 REMARK 3 7 2.5900 - 2.4600 1.00 2723 139 0.1619 0.2287 REMARK 3 8 2.4600 - 2.3500 1.00 2725 147 0.1541 0.1835 REMARK 3 9 2.3500 - 2.2600 1.00 2716 138 0.1552 0.2006 REMARK 3 10 2.2600 - 2.1800 1.00 2749 136 0.1540 0.1912 REMARK 3 11 2.1800 - 2.1100 1.00 2692 154 0.1568 0.2378 REMARK 3 12 2.1100 - 2.0500 1.00 2729 121 0.1558 0.2029 REMARK 3 13 2.0500 - 2.0000 1.00 2698 162 0.1496 0.1828 REMARK 3 14 2.0000 - 1.9500 1.00 2724 149 0.1654 0.2157 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.810 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 3796 REMARK 3 ANGLE : 1.322 5138 REMARK 3 CHIRALITY : 0.072 567 REMARK 3 PLANARITY : 0.010 656 REMARK 3 DIHEDRAL : 6.466 509 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -32.3470 6.5730 0.4007 REMARK 3 T TENSOR REMARK 3 T11: 0.1730 T22: 0.1166 REMARK 3 T33: 0.1755 T12: 0.0124 REMARK 3 T13: -0.0098 T23: 0.0102 REMARK 3 L TENSOR REMARK 3 L11: 0.4933 L22: 0.5356 REMARK 3 L33: 1.1594 L12: -0.0008 REMARK 3 L13: 0.0018 L23: 0.4027 REMARK 3 S TENSOR REMARK 3 S11: 0.0085 S12: -0.0020 S13: -0.1165 REMARK 3 S21: 0.0827 S22: -0.0111 S23: -0.0503 REMARK 3 S31: 0.2683 S32: 0.0723 S33: 0.0043 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8IL7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1300035935. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-22 REMARK 200 TEMPERATURE (KELVIN) : 193 REMARK 200 PH : 3.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL18U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40207 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 49.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 14.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE TRIBASIC, 15% PEG REMARK 280 3350, 0.1 M SODIUM LACTATE PH 3.8, 10% GLYCEROL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.28200 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.28200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.28200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 53850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 -49.64000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 85.97900 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -99.28000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 GLY A 138 REMARK 465 LEU A 139 REMARK 465 ASP A 140 REMARK 465 ILE A 141 REMARK 465 LYS A 468 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 10 35.75 -97.11 REMARK 500 ASP A 159 -157.30 -122.21 REMARK 500 ASP A 209 11.87 59.37 REMARK 500 ASP A 258 96.74 -164.80 REMARK 500 ASP A 339 48.61 38.29 REMARK 500 LYS A 378 -0.72 79.13 REMARK 500 REMARK 500 REMARK: NULL DBREF 8IL7 A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 8IL7 HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 8IL7 HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 8IL7 HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 8IL7 HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 8IL7 HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 8IL7 HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 8IL7 CME A 253 CYS MODIFIED RESIDUE HET CME A 253 10 HET 2OP A 501 6 HET GOL A 502 6 HET GOL A 503 6 HET GOL A 504 6 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM 2OP (2S)-2-HYDROXYPROPANOIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 2OP C3 H6 O3 FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 HOH *254(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 ILE A 48 ALA A 53 1 6 HELIX 4 AA4 MET A 54 SER A 60 1 7 HELIX 5 AA5 ALA A 61 MET A 64 5 4 HELIX 6 AA6 ARG A 66 PHE A 89 1 24 HELIX 7 AA7 GLU A 108 LYS A 110 5 3 HELIX 8 AA8 GLN A 111 PHE A 130 1 20 HELIX 9 AA9 GLY A 169 ALA A 182 1 14 HELIX 10 AB1 SER A 190 CYS A 197 1 8 HELIX 11 AB2 ASN A 225 THR A 235 1 11 HELIX 12 AB3 SER A 242 LYS A 246 5 5 HELIX 13 AB4 ARG A 250 LEU A 255 5 6 HELIX 14 AB5 ASP A 258 LYS A 267 1 10 HELIX 15 AB6 MET A 270 ASP A 278 1 9 HELIX 16 AB7 LYS A 306 PHE A 328 1 23 HELIX 17 AB8 ASP A 357 SER A 374 1 18 HELIX 18 AB9 GLY A 408 TYR A 421 1 14 HELIX 19 AC1 ASP A 428 SER A 435 1 8 HELIX 20 AC2 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 ALA A 97 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA1 5 PHE A 35 ASP A 47 -1 N VAL A 46 O LEU A 101 SHEET 4 AA1 5 LYS A 144 GLY A 158 -1 O LYS A 144 N ASP A 47 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O LEU A 166 N LEU A 155 SHEET 1 AA2 7 ASP A 92 ALA A 97 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O ALA A 100 N ALA A 97 SHEET 3 AA2 7 PHE A 35 ASP A 47 -1 N VAL A 46 O LEU A 101 SHEET 4 AA2 7 LYS A 144 GLY A 158 -1 O LYS A 144 N ASP A 47 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 GLN A 210 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 VAL A 207 -1 N GLU A 203 O ASN A 216 SHEET 1 AA3 5 GLN A 331 PHE A 338 0 SHEET 2 AA3 5 GLY A 341 PHE A 348 -1 O LEU A 345 N ASN A 333 SHEET 3 AA3 5 GLU A 288 PHE A 301 -1 N VAL A 297 O PHE A 344 SHEET 4 AA3 5 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O ILE A 407 N PHE A 392 SHEET 1 AA4 7 GLN A 331 PHE A 338 0 SHEET 2 AA4 7 GLY A 341 PHE A 348 -1 O LEU A 345 N ASN A 333 SHEET 3 AA4 7 GLU A 288 PHE A 301 -1 N VAL A 297 O PHE A 344 SHEET 4 AA4 7 ILE A 379 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 460 N CYS A 427 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.33 CISPEP 1 ARG A 33 PRO A 34 0 0.58 CRYST1 99.280 99.280 98.564 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010073 0.005815 0.000000 0.00000 SCALE2 0.000000 0.011631 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010146 0.00000